A multicenter, randomized, double-blind, placebo-controlled study of the efficacy and safety of Siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with Multicentric Castleman's disease

被引：0

作者：

Hess, G. ^{[1
]}

Kirsch, A. ^{[2
]}

Wong, R. S. ^{[3
]}

Casper, C. ^{[4
]}

Munshi, N. ^{[5
]}

Fossa, A. ^{[6
]}

Cavet, J. ^{[7
]}

Bandekar, R. ^{[8
]}

Rothman, M. ^{[9
]}

Puchalski, T. A.

Chaturvedi, S.

van de Velde, H. ^{[10
]}

Vermeulen, J. ^{[11
]}

van Rhee, F. ^{[12
]}

机构：

[1] Johannes Gutenberg Univ Mainz, Med Klin & Poliklin 3, D-55122 Mainz, Germany

[2] Med Versorgungszentrum Onkol Schwerpunkt Oskar He, Berlin, Germany

[3] Chinese Univ Hong Kong, Prince Wales Hosp, Hong Kong, Hong Kong, Peoples R China

[4] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA

[5] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA

[6] Norwegian Radium Hosp, Oslo, Norway

[7] Christie NHS Fdn Trust, Manchester, Lancs, England

[8] Janssen Res & Dev, Spring House, PA USA

[9] Janssen Res & Dev, Washington, DC USA

[10] Janssen Res & Dev, Beerse, Belgium

[11] Janssen Res & Dev, Leiden, Netherlands

[12] Univ Arkansas Med Sci, Myeloma Inst Res & Therapy, Little Rock, AR 72205 USA

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2014年 / 37卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P251

引用

页码：77 / 77

页数：1

共 50 条

[31] Efficacy and safety of artesunate for patients with IgA nephropathy: a study protocol for a multicenter, double-blind, randomized, placebo-controlled trial
Qi Chen
Zi Wang
Jicheng Lv
Lijun Liu
Hang Li
Weiwei Sun
Yanhong Huo
Yingbo Guo
Cun Shen
Shichao Li
Zhenjie Chen
Jingwei Zhou
Trials, 23
[32] Efficacy and safety of Yirui capsule in patients with hyperlipidemia: study protocol for a multicenter, randomized, double-blind, placebo-controlled trial
Dai, Liang
Zhong, Linda L. D.
Cao, Yan
Chen, Wei
Cheng, Ying
Lin, Xiu-Fang
Bian, Zhao-Xiang
Lu, Ai-Ping
TRIALS, 2016, 17
[33] Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of Siltuximab in High-Risk Smoldering Multiple Myeloma
Brighton, Timothy A.
Khot, Amit
Harrison, Simon J.
Ghez, David
Weiss, Brendan M.
Kirsch, Andres
Magen, Hila
Gironella, Mercedes
Oriol, Albert
Streetly, Matthew
Kranenburg, Britte
Qin, Xiang
Bandekar, Rajesh
Hu, Peter
Guilfoyle, Mary
Qi, Ming
Nemat, Sepideh
Goldschmidt, Hartmut
CLINICAL CANCER RESEARCH, 2019, 25 (13) : 3772 - 3775
[34] A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Teprenone in Patients with Alzheimer's Disease
Yokoyama, Shunichi
Yoshinaga, Takuma
Matsuzaki, Juntaro
Suzuki, Hidekazu
JOURNAL OF ALZHEIMERS DISEASE, 2019, 71 (04) : 1187 - 1199
[35] EFFICACY AND SAFETY OF QUETIAPINE FOR DELIRIUM IN ICU PATIENTS:A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
Devlin, John W.
Roberts, Russel
Fong, Jeffrey J.
Skrobik, Yoanna
Harvey, Johanne
Riker, Richard
Robbins, Tracey
Hill, Nicholas
Garpestad, Erik
CRITICAL CARE MEDICINE, 2008, 36 (12) : A17 - A17
[36] Efficacy and safety of rasagiline monotherapy in Japanese patients with early Parkinson's disease: A phase 3, randomized, double-blind, placebo-controlled, multicenter study
Hattori, N.
Takeda, A.
Takeda, S.
Nishimura, A.
Kitagawa, T.
Mochizuki, H.
Nagai, M.
Takahashi, R.
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 231 - 232
[37] Multicenter, randomized, double-blind, placebo-controlled, parallel trial comparing the safety and efficacy of rufinamide
Biton, V
Rosenfeld, W
Schachter, S
Perdomo, C
Arroyo, S
ANNALS OF NEUROLOGY, 2005, 58 : S114 - S114
[38] THE EFFICACY AND SAFETY OF LURASIDONE IN ADOLESCENT PATIENTS WITH SCHIZOPHRENIA: A 6-WEEK, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY
Goldman, Robert S.
Findling, Robert L.
Silva, Robert M.
Cucchiaro, Josephine B.
Deng, Ling
Loebel, Antony
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2016, 55 (10): : S163 - S164
[39] Efficacy and safety of tacrolimus for lupus nephritis: a placebo-controlled double-blind multicenter study
Miyasaka, Nobuyuki
Kawai, Shinichi
Hashimoto, Hiroshi
MODERN RHEUMATOLOGY, 2009, 19 (06) : 606 - 615
[40] A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting
Tariot, PN
Cummings, JL
Katz, IR
Mintzer, J
Perdomo, CA
Schwam, EM
Whalen, E
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2001, 49 (12) : 1590 - 1599

← 1 2 3 4 5 →